Household contacts were key factor for children's colonization with resistant Escherichia coli in community setting

Journal of Clinical Epidemiology

Volumn 60, Issue 11, 2007, Pages 1149-1155

  Lietzau, Susanne ^a   Raum, Elke ^a,b   von Baum, Heike ^c   Marre, Reinhard ^c   Brenner, Hermann ^a,b  

^a GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Antibiotic resistance; Bacterial; Children; E. coli; Household; Transmission

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFPODOXIME PROXETIL; CEFUROXIME; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; NALIDIXIC ACID; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; COMMUNITY; ESCHERICHIA COLI; GERMANY; HOUSEHOLD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SIBLING;

AGE DISTRIBUTION; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GERMANY; HUMANS; INFANT; MALE; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; RISK FACTORS; SIBLINGS; SOCIOECONOMIC FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 35148821051     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2007.01.016     Document Type: Article

References (24)

1. Goettsch W., van Pelt W., Nagelkerke N., Hendrix M.G., Buiting A.G., Petit P.L., et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 46 (2000) 223-228
2. Howard D.H., Scott II R.D., Packard R., and Jones D. The global impact of drug resistance. Clin Infect Dis 36 (2003) S4-S10
3. Livermore D.M. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 36 (2003) S11-S23
4. Jakobsson B., Berg U., and Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 70 (1994) 111-115
5. Jodal U. The natural history of bacteriuria in childhood. Infect Dis Clin North Am 1 (1987) 713-729
6. Larcombe J. Urinary tract infection in children. BMJ 319 (1999) 1173-1175
7. Siegel S.R., Siegel B., Sokoloff B.Z., and Kanter M.H. Urinary infection in infants and preschool children. Five-year follow-up. Am J Dis Child 134 (1980) 369-372
8. Brumfitt W., Faiers M.C., Reeves D.S., and Datta N. Antibiotic-resistant Escherichia coli causing urinary-tract infection in general practice: relation to faecal flora. Lancet 1 (1971) 315-317
9. Allen U.D., MacDonald N., Fuite L., Chan F., and Stephens D. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 160 (1999) 1436-1440
10. Macias A.E., Herrera L.E., Munoz J.M., and Medina H. Antibiotic-resistant fecal Escherichia coli in healthy children. Induced by the use of antibiotics?. Rev Invest Clin 54 (2002) 108-112 [Article in Spanish]
11. Murray B.E., Rensimer E.R., and DuPont H.L. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N Engl J Med 306 (1982) 130-135
12. Fornasini M., Reves R.R., Murray B.E., Morrow A.L., and Pickering L.K. Trimethoprim-resistant Escherichia coli in households of children attending day care centers. J Infect Dis 166 (1992) 326-330
13. Reves R.R., Murray B.E., Pickering L.K., Prado D., Maddock M., and Bartlett III A.V. Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers. J Infect Dis 156 (1987) 758-762
14. Reves R.R., Fong M., Pickering L.K., Bartlett III A., Alvarez M., and Murray B.E. Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas. Antimicrob Agents Chemother 34 (1990) 1429-1434
15. Stürmer T., Erb A., Marre R., and Brenner H. Prevalence and determinants of antibiotic resistance in faecal Escherichia coli among unselected patients attending general practitioners in Southwest Germany. Pharmacoepidemiol Drug Saf 13 (2004) 303-308
16. Rydberg J., and Cederberg A. Intrafamilial spreading of Escherichia coli resistant to trimethoprim. Scand J Infect Dis 18 (1986) 457-460
17. German Institute for Standardization (DIN). Medical microbiology-Susceptibility testing of microbial pathogens to antimicrobial agents (Medizinische Mikrobiologie und Immunologie. E 58 940 Part 4: Methoden zur Empfindlichkeitsprüfung von bakteriellen Krankheitserregern (außer Mykobakterien) gegen Chemotherapeutika). [Book in German] (2002), Beuth, Berlin
18. Lester S.C., del Pilar Pla M., Wang F., Perez Schael I., Jiang H., and O'Brien T.F. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med 323 (1990) 285-289
19. Cars O., Molstad S., and Melander A. Variation in antibiotic use in the European Union. Lancet 357 (2001) 1851-1853
20. Garau J., Xercavins M., Rodriguez-Carballeira M., Gomez-Vera J.R., Coll I., Vidal D., et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 43 (1999) 2736-2741
21. Dominguez E., Zarazaga M., Saenz Y., Brinas L., and Torres C. Mechanisms of antibiotic resistance in Escherichia coli isolates obtained from healthy children in Spain. Microb Drug Resist 8 (2002) 321-327
22. Kresken M., Hafner D., Schmitz F.J., and Wichelhaus T. Paul-Ehrlich-Society of chemotherapy: resistance prevalence study (Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. Resistenzstudie 2004) (2004). http://www.p-e-g.org/ag_resistenz/main.htm [German] Accessed December 11, 2006
23. Günther J., Kern W., Nink K., Schroeder H., and de With K. As long as they are effective. Analyses and comments of the antibiotic consumption in Germany (Solange sie noch wirken. Analyse und Kommentare zum Antibiotikaverbrauch in Deutschland) (2003), Wissenschaftliches Institut der Allgemeinen Ortskrankenkasse an der Universität Freiburg, Bonn/Freiburg [Book in German]
24. Schwabe U., and Paffrath D. Drug-prescription-report 2002 (Arzneiverordnungsreport 2002) (2003), Springer, Berlin, Heidelberg [Book in German]